An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex(®) (THC:CBD, nabiximols) oromucosal spray - Etges, T; Karolia, K; Grint, T (Ther Clin Risk Manag, 2016)